Youssef Chami, MD
Education
Grants
Site Principal Investigator:
Site Co-Investigators:
Grant from the Medicines Company. "A clinical trial comparing treatment with cangrelor (in combination with usual care) to usual care, in subjects who require percutaneious coronary intervention." Conducted: 2008-Present
Grant from Genentech, Inc: "A Randomized Trial Evaluating Low-Dose IntraCoronary Adjunctive Tenecteplase During Primary PCI for ST-Elevation Myocardial Infarction." Conducted: 2008-Present
Grant from CardioMems. "Cardiomems heart sensor allows monitoring of pressure to improve outcomes in NYHA class III heart failure patients." Conducted: 2008-Present
Grant from Abbott Vascular Devices. "Emboshield and Xact Post Approval Carotid Stent Trial using the Ernoshield" BareWire® Rapid Exchange Embolic and Xact" Rapid Exchange Carotid Stent System." Conducted: 2006-Present
Grant from GlaxoSmithKline. "An Open, Nonrandomized Comparison of Pharmacokinetic Profiles of Carvedilol (SK&F-105517) MR and IR on Repeat Dosing in Chronic CHF Patients and Survivors of an Acute MI and LVD./I Conducted: 2005
Grant from Sterotaxis. "Interventional Cardiology Prospective Data and Analysis for Conventional Cases." Conducted: 2005-2006
Grant from Schering-Plough Research Institue: "A Multicenter, Double-Blind, Randomized Study to Establish the Clinical Benefit and Safety of Vytorin (Ezetimibe/Simvastatin Tablet) vs Simvastatin Monotherapy in High-Rish Subjects Presenting with Acute Coronary Syndrome." Conducted: 2005-Present
Grant from Novartis Pharmaceuticals. "A 6-week, multicenter, randomized, double-blind, parallel-group study to evaluate the combination of valsartan/HCTZ (160/12.5 mg with forced titration to a maximum dose of 320/25 mg) compared to valsartan monotherapy (160 mg with forced titration to 320 mg) as initial therapy in patients with severe hypertension." Conducted: 2005-Present
Grant from Lilly Research Institute. "A Comparison of CS-747 and Clopidogrel in acute coronary syndrome subjects who are undergo percutaneous coronary intercention-TIMI 38." Conducted: 2005-Present
Grant from Cordis. "DEScover Registry Protocol." Conducted: 2005-Present
Grant from the Medicines Company. "A trial fibrillation Clopidogrel Trials with Irbesartan for prevention of Vascular Events - ACTIVE, A parallel randomized controlled evaluation of clopidogrel plus aspirin, with factorial evaluation of Irbesartan for prevention of vascular events, in patients with atrial fibrillation (EFC4912)." Conducted: 2004-Present
Grant from Sanofi-Aventis. "Atrial fibrillation Clopidogrel Trials with Irbesartan for prevention of Vascular Events - ACTIVE, A parallel randomized controlled evaluation of clopidogrel plus aspirin, with factorial evaluation of Irbesartan, for the prevention of vascular events, in patients with atrial fibrillation (EFC4912)." Conducted: 2004-Present
Grant from Guidant. "Carotid RX ACCULINK/ACCUNET Post Approval Trial to Uncover Unanticipated of Rare Events." Conducted 2004-Present
Grant from Centocor: "A multicenter, randomized, double-blind, placebo-controlled trial comparing the efficacy and safety of Reteplase and Abeiximab combination therapy with Abeiximab alone administered early or just prior to Primary Percutaneious Coronary Intervention for Acute Myocardiallnfaraction (FINESSE: Protocol No. COl16T40)." Conducted: 2004
Grant from Medtronic. "A Multicenter, Non-inferiority Randomized, Controlled Trial to Evaluate the Safety and Efficacy of the Medtronic AVE interceptor' Coronary Filter System in Subjects with DE NOVO and Restenotic Lesions of Saphenous Vein Grafts." Conducted: 2004
Grant from Spectronectics. "Coronary graft results following atherectomy with laser." Conducted: 2004-2005
Grant from Possis Medical Inc. "AngioJet Rheolytic Thrombectomy in Patients Undergoing Primary Angioplasty for Acute Mvocardtal tnfarctlon." Conducted: 2003-2005
Grant from Aventis Pharmaceutical, Inc. "Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment" Conducted: 20003-2005
Grant from Theragenics. itA Safety and Feasibility Study of Use of the Terasource' Intravascular Brachytherapy System for Prevention of Restenosis Following Successful Percutaneoua Transluminal Angioplasty (PTA) in the Superficial Femoral and Popliteal Arteries." Conducted 2003-2004
Grant from Millennium Pharmaceuticals, Inc. "A randomized trial to evaluate the relative protection against post-PCI microvascular dysfunction and post-PCI ischemia among anti-platelet and anti-thrombotic agents." Conducted: 2003-2004
Aggrastat to Zocor Study: A multicenter, randomized, controlled, double-blind trial to investigate the clinical efficacy and tolerability of early treatment with Simvastatin 40mg daily for 30 Days, followed by Simvastatin 80mg daily thereafter in Tirofiban treated Acute Coronary Syndrome patients who have been randomized to receive Enoxaparin or Unfractionated Heparin in conjunction with Aspirin. Conducted: 2001-2002